Press releases
Welcome to CGM symposium in Bergen
Can the everyday lives of diabetes patients be revolutionized through technology?
The world experiences a record number of people with diabetes. How has diabetes technology evolved over the last 40 years, and how can a Norwegian medtech company contribute to increased patient safety and comfort?
- What are the latest trends?
- What technological advancements can we expect?
- How will artificial intelligence and advanced analytics shape the future of treatment?
To highlight the advancements in Continuous Glucose Monitoring (CGM), Lifecare, in collaboration with Eitri and Bergen Chamber of Commerce and Industry, has gathered renowned international experts for an engaging symposium. Among the keynote speakers is Prof. David Klonoff, who has served as an advisor to institutions such as the White House and NASA, as well as the founder of the Diabetes Technology Society and the Hospital Diabetes Meeting.
We are witnessing an exciting development within the healthcare industry in Bergen. The Bergen-based company Lifecare ASA is developing a groundbreaking method for diabetes patients to monitor their glucose levels.
Globally, more than half a billion people are affected by diabetes. In Norway, five percent of the adult population has the disease. Each year, the prevalence increases, and in 20 years, an additional 200 million patients are expected. The WHO refers to diabetes as the great pandemic. Many diabetes patients rely on technology that continuously monitors glucose levels in their bodies.
According to the International Diabetes Federation, diabetes-related healthcare costs amounted to nearly 1,000 billion dollars in 2021, reflecting a 316% increase over the past 15 years. In 2021 alone, 6.7 million people worldwide died due to diabetes.
The goal of this symposium is to provide valuable insights from leading experts into how glucose monitoring has evolved—from its early solutions to today’s state-of-the-art sensors and future innovations. What are the latest trends? What technological advancements can we expect? And how will artificial intelligence and advanced analytics shape the future of diabetes treatment? This is a development that could be transformative for a growing patient population.
To highlight the advancements in Continuous Glucose Monitoring (CGM), Lifecare, in collaboration with Eitri and Bergen Chamber of Commerce and Industry, has gathered renowned international experts for an engaging symposium. Among the keynote speakers is Prof. David Klonoff, who has served as an advisor to institutions such as the White House and NASA, as well as the founder of the Diabetes Technology Society and the Hospital Diabetes Meeting.
As a patient, relative, researcher, or healthcare professional, you will gain valuable insights into the evolution of glucose monitoring—from early solutions to today’s state-of-the-art sensors and future innovations. This is a unique opportunity to explore how future technology can improve the quality of life for millions of people.
Please register here to participate (Norwegian)